Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Clinical Trial ID NCT00106353

PubWeight™ 4.05‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00106353

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase I study of temsirolimus in pediatric patients with recurrent/refractory solid tumors. J Clin Oncol 2011 1.18
2 Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma. Eur J Cancer 2011 1.15
3 New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. Clin Cancer Res 2013 1.02
4 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
Next 100